Any of these new HCC cells isolated from patients increased their migratory capacity in response to TGF-β, since they are already mesenchymal, but it was very interesting to observe that galunisertib was able to inhibit the basal migratory capacity of the HLC21 cells, correlated with a decreased expression of N-cadherin. Here, CDH2 is linked to hepatocellular carcinoma.